| NUVB |
Nuvation Bio Inc. |
27 Feb 2026 |
1 |
$0 |
4 |
Director |
03 Mar 2026, 19:58 |
| NUVB |
Nuvation Bio Inc. |
03 Sep 2024 |
12 |
$0 |
4 |
Director |
05 Sep 2024, 16:15 |
| NUVB |
Nuvation Bio Inc. |
25 Jun 2024 |
1 |
+$825,348 |
4 |
Director |
26 Jun 2024, 16:31 |
| NUVB |
Nuvation Bio Inc. |
20 Jun 2024 |
3 |
+$1,492,385 |
4 |
Director |
25 Jun 2024, 17:45 |
| /report/000162619924000095-cui-xiangmin-2024-05-18 |
ALPINE IMMUNE SCIENCES, INC. |
18 May 2024 |
8 |
$0 |
4 |
Director, 10%+ Owner |
20 May 2024, 20:08 |
| NUVB |
Nuvation Bio Inc. |
09 Apr 2024 |
3 |
$0 |
4 |
Director |
11 Apr 2024, 21:01 |
| NUVB |
Nuvation Bio Inc. |
09 Apr 2024 |
0 |
$0 |
3 |
Director |
11 Apr 2024, 20:58 |
| /report/000120919124002014-cui-xiangmin-2024-01-18 |
ALPINE IMMUNE SCIENCES, INC. |
18 Jan 2024 |
2 |
+$15,729,263 |
4 |
Director, 10%+ Owner |
22 Jan 2024, 17:48 |
| /report/000162619924000010-cui-xiangmin-2024-01-02 |
ALPINE IMMUNE SCIENCES, INC. |
02 Jan 2024 |
1 |
$0 |
4 |
Director, 10%+ Owner |
04 Jan 2024, 19:03 |
| /report/000120919123055208-cui-xiangmin-2023-11-09 |
ALPINE IMMUNE SCIENCES, INC. |
09 Nov 2023 |
1 |
+$4,687,500 |
4 |
Director, 10%+ Owner |
14 Nov 2023, 17:33 |
| /report/000162619923000015-cui-xiangmin-2023-01-03 |
ALPINE IMMUNE SCIENCES, INC. |
03 Jan 2023 |
1 |
$0 |
4 |
Director, 10%+ Owner |
05 Jan 2023, 17:55 |
| /report/000120919122051372-cui-xiangmin-2022-09-23 |
ALPINE IMMUNE SCIENCES, INC. |
23 Sep 2022 |
2 |
+$14,700,000 |
4 |
Director, 10%+ Owner |
27 Sep 2022, 16:51 |
| /report/000162619922000004-cui-xiangmin-2022-01-03 |
ALPINE IMMUNE SCIENCES, INC. |
03 Jan 2022 |
1 |
$0 |
4 |
Director, 10%+ Owner |
04 Jan 2022, 16:17 |
| /report/000114036121033147-cui-xiangmin-2021-09-28 |
Cue Health Inc. |
28 Sep 2021 |
3 |
+$10,092,045 |
4 |
Director |
30 Sep 2021, 17:43 |
| /report/000114036121032361-cui-xiangmin-2021-09-23 |
Cue Health Inc. |
23 Sep 2021 |
0 |
$0 |
3 |
Director, 10%+ Owner |
23 Sep 2021, 21:06 |
| /report/000162619921000112-cui-xiangmin-2021-09-17 |
ALPINE IMMUNE SCIENCES, INC. |
17 Sep 2021 |
1 |
+$14,499,998 |
4 |
Director, 10%+ Owner |
21 Sep 2021, 17:12 |